Live from the NIH registry
Studies recruiting near Santa Cruz right now
Top 25 of 168 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (0.4 mi)
· Sponsor: SWOG Cancer Research Network
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Kaiser Permanente - Santa Clara ( Site 0082) — Santa Clara, California (26.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — San Jose, California (26.1 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Salinas, California (29.5 mi)
· Sponsor: Medtronic
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (26.1 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Palo Alto Medical Foundation-Sunnyvale — Sunnyvale, California (26.9 mi)
· Sponsor: NRG Oncology
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Lumos Clinical Research Center /ID# 249731 — San Jose, California (26.1 mi)
· Sponsor: AbbVie
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Immunoglobulin G4 Related Disease
Phase 3
Interventional 124 participants sought
San Jose Clinical Trials- Site Number : 8400016 — San Jose, California (26.1 mi)
· Sponsor: Sanofi
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (0.4 mi)
· Sponsor: NRG Oncology
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
Phase 3
Interventional 600 participants sought
Clinical Study Site — Santa Clara, California (26.3 mi)
· Sponsor: Summit Therapeutics
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Multiple Myeloma
Phase 1
Interventional 134 participants sought
Pacific Cancer Care — Monterey, California (27.3 mi)
· Sponsor: Oncotherapeutics
Quadriceps Strengthening ACL Reconstruction
ACL Tear
N/A
Interventional 20 participants sought
Stanford Medicine Children's Health — Sunnyvale, California (26.9 mi)
· Sponsor: Stanford University
Toddlers' Responses to Strangers
Social Behavior
N/A
Observational 100 participants sought
Social Science 2 Building — Santa Cruz, California (0.4 mi)
· Sponsor: University of California Santa Cruz
Generative AI Plan for Care Lab Study
Primary Health Care
N/A
Interventional 40,000 participants sought
Google LLC — Mountain View, California (28.3 mi)
· Sponsor: Fitbit LLC
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation
N/A
Observational 538 participants sought
Stanford Cancer Center South Bay — San Jose, California (26.1 mi)
· Sponsor: PrECOG, LLC.
Study of Student Flourishing
Healthy
N/A
Interventional 2,500 participants sought
Foothill College — Los Altos Hills, California (28.3 mi)
· Sponsor: Flourish Science, Inc.
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Lung Cancer
Phase 1
Interventional 45 participants sought
Stanford Cancer Center South Bay — San Jose, California (26.1 mi)
· Sponsor: Stanford University
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (26.1 mi)
· Sponsor: NRG Oncology
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 3
Interventional 94 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (0.4 mi)
· Sponsor: SWOG Cancer Research Network
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (0.4 mi)
· Sponsor: NRG Oncology
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Lung Non-Small Cell Carcinoma
Phase 2
Interventional 88 participants sought
Palo Alto Medical Foundation-Sunnyvale — Sunnyvale, California (26.9 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 480 participants sought
Kaiser Permanente Santa Clara Medical Center — Santa Clara, California (26.3 mi)
· Sponsor: Janssen Research & Development, LLC
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Type 1 Diabetes
Phase 2
Interventional 159 participants sought
San Jose Clinical Trials, LLC — San Jose, California (26.1 mi)
· Sponsor: SAb Biotherapeutics, Inc.
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12064 — San Jose, California (26.1 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling
Human Papilloma Virus
N/A
Observational 5,000 participants sought
Atila Biosystems, Inc. — Sunnyvale, California (26.9 mi)
· Sponsor: Atila Biosystems Inc.